晚期胃癌的维持治疗

国际肿瘤学杂志 Pub Date : 2019-07-08 DOI:10.3760/CMA.J.ISSN.1673-422X.2019.07.011

Yang Yao, Yingjie Jia, R. Deng, Xiaojiang Li

{"title":"晚期胃癌的维持治疗","authors":"Yang Yao, Yingjie Jia, R. Deng, Xiaojiang Li","doi":"10.3760/CMA.J.ISSN.1673-422X.2019.07.011","DOIUrl":null,"url":null,"abstract":"S-1 and capecitabine are relatively ideal agents for maintenance treatment of advanced gastric cancer. In clinical trials of using immune and targeted drugs for maintenance treatment of advanced gastric cancer, ipilimumab fails to obtain positive results, ramucirumab has not obtained research data, and trial regimens of maintenance treatment with trastuzumab, bevacizumab and avelumab have all shown initial efficacy. Traditional Chinese medicine therapy has shown some effectiveness in maintenance treatment, which still needs further researches. \n \n \nKey words: \nStomach neoplasms; Drug therapy; Maintenance treatment","PeriodicalId":16120,"journal":{"name":"国际肿瘤学杂志","volume":"174 1","pages":"439-442"},"PeriodicalIF":0.0000,"publicationDate":"2019-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Maintenance treatment for advanced gastric cancer\",\"authors\":\"Yang Yao, Yingjie Jia, R. Deng, Xiaojiang Li\",\"doi\":\"10.3760/CMA.J.ISSN.1673-422X.2019.07.011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"S-1 and capecitabine are relatively ideal agents for maintenance treatment of advanced gastric cancer. In clinical trials of using immune and targeted drugs for maintenance treatment of advanced gastric cancer, ipilimumab fails to obtain positive results, ramucirumab has not obtained research data, and trial regimens of maintenance treatment with trastuzumab, bevacizumab and avelumab have all shown initial efficacy. Traditional Chinese medicine therapy has shown some effectiveness in maintenance treatment, which still needs further researches. \\n \\n \\nKey words: \\nStomach neoplasms; Drug therapy; Maintenance treatment\",\"PeriodicalId\":16120,\"journal\":{\"name\":\"国际肿瘤学杂志\",\"volume\":\"174 1\",\"pages\":\"439-442\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-07-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"国际肿瘤学杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1673-422X.2019.07.011\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"国际肿瘤学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1673-422X.2019.07.011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

S-1和卡培他滨是较为理想的晚期胃癌维持治疗药物。在使用免疫和靶向药物维持治疗晚期胃癌的临床试验中，伊匹单抗未能获得阳性结果，拉穆单抗未获得研究数据，曲妥珠单抗、贝伐单抗和阿维单抗维持治疗的试验方案均显示出初步疗效。中医疗法在维持治疗方面已显示出一定的疗效，但仍需进一步研究。关键词:胃肿瘤;药物治疗;维持治疗

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Maintenance treatment for advanced gastric cancer

S-1 and capecitabine are relatively ideal agents for maintenance treatment of advanced gastric cancer. In clinical trials of using immune and targeted drugs for maintenance treatment of advanced gastric cancer, ipilimumab fails to obtain positive results, ramucirumab has not obtained research data, and trial regimens of maintenance treatment with trastuzumab, bevacizumab and avelumab have all shown initial efficacy. Traditional Chinese medicine therapy has shown some effectiveness in maintenance treatment, which still needs further researches. Key words: Stomach neoplasms; Drug therapy; Maintenance treatment

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

国际肿瘤学杂志

自引率

0.00%

发文量

12123

期刊介绍：